KD025-208: A Phase 2a Study of KD025 for Patients With Chronic Graft Versus Host Disease (cGVHD)-Pharmacodynamics and Updated Results

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:8 / 9
页数:2
相关论文
共 50 条
  • [31] Peginterferon-α-2a (40kD) and Ribavirin in Patients with Chronic Hepatitis CA Phase II Open-Label Study
    Mark Sulkowski
    Robert Reindollar
    David L. Thomas
    Sherilyn Brinkley-Laughton
    Martha Hudson
    Jian Yu
    BioDrugs, 2002, 16 : 105 - 109
  • [32] Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study
    Carpenter, Paul A.
    Kang, Hyoung Jin
    Yoo, Keon Hee
    Zecca, Marco
    Cho, Bin
    Lucchini, Giovanna
    Nemecek, Eneida R.
    Schultz, Kirk R.
    Stepensky, Polina
    Chaudhury, Sonali
    Oshrine, Benjamin
    Khaw, Seong Lin
    Harris, Andrew C.
    Verna, Marta
    Zubarovskaya, Liudmila
    Lee, Yihua
    Wahlstrom, Justin
    Styles, Lori
    Shaw, Peter J.
    Dalle, Jean-Hugues
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (11): : 771.e1 - 771.e10
  • [33] Rituximab and total nodal irradiation in the treatment of extensive chronic graft-versus-host disease: interim results of a phase 2 study
    He, S.
    Wirth, A.
    Moore, J.
    Szer, J.
    Roberts, A.
    Peppin, J.
    Ritchie, D.
    Grigg, A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S409 - S410
  • [35] Phase II study of Pentostatin in patients with corticosteroid-refractory chronic graft-versus-host disease
    Jacobsohn, David A.
    Chen, Allen R.
    Zahurak, Marianna
    Piantadosi, Steven
    Anders, Viki
    Bolanos-Meade, Javier
    Higman, Meghan
    Margolis, Jeffrey
    Kaup, Michele
    Vogelsang, Georgia B.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (27) : 4255 - 4261
  • [36] A phase 1/2 dose-finding, safety, and efficacy study of ibrutinib in paediatric patients with chronic graft versus host disease
    Locatelli, Franco
    Shaw, Peter
    Luan, Ying
    Sukbuntherng, Juthamas
    Wahlstrom, Justin
    Styles, Lori
    Carpenter, Paul
    BONE MARROW TRANSPLANTATION, 2019, 54 : 545 - 546
  • [37] Results of extracorporeal photopheresis performed with 2 different techniques in 18 patients with chronic graft-versus-host disease
    Indovina, A
    Mannino, R
    Cavallaro, AM
    Tringali, S
    DiBella, R
    Scimè, R
    Cervello, AOV
    BONE MARROW TRANSPLANTATION, 2004, 33 : S183 - S183
  • [38] IBRUTINIB FOR CHRONIC GRAFT-VERSUS-HOST DISEASE AFTER FAILURE OF FRONTLINE CORTICOSTEROIDS: RESULTS OF A MULTICENTER OPEN-LABEL PHASE 2 STUDY
    Pusic, I.
    Miklos, D.
    Cutler, C.
    Arora, M.
    Waller, E.
    Jagasia, M.
    Flowers, M.
    Logan, A.
    Nakamura, R.
    Blazar, B.
    Li, Y.
    Lal, I.
    Dubovsky, J.
    James, D.
    Styles, L.
    Jaglowski, S.
    HAEMATOLOGICA, 2017, 102 : 186 - 186
  • [39] A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease
    Flowers, Mary E. D.
    Apperley, Jane F.
    van Besien, Koen
    Elmaagacli, Ahmet
    Grigg, Andrew
    Reddy, Vijay
    Bacigalupo, Andrea
    Kolb, Hans-Jochem
    Bouzas, Luis
    Michallet, Mauricette
    Prince, H. Miles
    Knobler, Robert
    Parenti, Dennis
    Gallo, Jose
    Greinix, Hildegard T.
    BLOOD, 2008, 112 (07) : 2667 - 2674
  • [40] A Phase 1 Open Label, Multi-Center, Dose Escalation Study of Nilotinib (NLT) in Steroid Dependent/Refractory Chronic Graft-Versus-Host Disease (cGvHD)
    Chen, George L.
    Carpenter, Paul A.
    Broady, Raewyn
    Gregory, Tara
    Arai, Sally
    Johnston, Laura
    Flowers, Mary E. D.
    McCarthy, Philip L.
    Liu, Hong
    Ross, Maureen
    Mendelsohn, Jodie
    Beumer, Jan H.
    Christner, Susan
    Cipolla, Dana
    Wong, Irene
    Lam, Melanie
    Provost, Marie
    Snider, Vicki
    Beethe, Patricia
    Perloff, Spenser
    Schoenrock, Kelsi
    Otani, Joanne
    Miklos, David B.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (02) : S319 - S320